Head and Neck Cancer Market Research Report: By type
(Laryngeal, Pharyngeal, Salivary Gland, Oral Cavity, Nasopharyngeal), by
Diagnosis (Blood Test, Endoscopy, others), by Treatment (Chemotherapy, Surgery,
Others), by End-User – Global Forecast Till 2023
Market
Highlights
It is
estimated that the Head and Neck Cancer Market is expected to grow at a CAGR 9.5% during the
forecast period of 2019–2023.Head and neck cancers are site-specific, which
includes oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and
salivary glands. The consumption of alcohol and tobacco are the two most common
risk factors for head and neck cancers.
A number
of factors such as the increasing prevalence of head and neck cancers, growing
geriatric population, huge research funding in oncology, unmet medical needs,
rising competition among market players, improving regulatory framework, aging
population, and increasing government assistance, are a few factors propelling
the growth of the global ophthalmic drugs market. According to the 2014
statistics suggested by the World Health Organization (WHO), the annual
incidence rate of head and neck cancer is more than 550,000 cases with nearly
300,000 deaths each year, worldwide.
However,
the high cost associated with treatment approach, side effects of available
treatment options, lack of healthcare coverage, and poor healthcare system in
low- and middle-income countries may hamper the growth of the market.
Regional
Analysis
The
Americas dominates the head and neck cancer market owing to the presence of
patient population, rising prevalence of head and neck cancer, well-developed
technology, high healthcare expenditure, and the presence of the leading market
players. The head and neck cancer account for nearly 3% of all the cancers in
the United States. In 2017, around 63,030 people developed head and neck
cancer.
Europe holds
the second position in the head and neck cancer market. It is expected that the
research and development expenditure provided by the government and private
associations, increasing competition among marketers, rising healthcare
expenditure, and amendments in reimbursement policies in healthcare are likely
to drive the European head and neck cancer market.
Asia
Pacific is the fastest growing head and neck cancer market owing to a huge
patient pool, increasing demand, and development of the healthcare technology.
The
Middle East and Africa holds the lowest share of the global head and neck
cancer market due to low development, lack of technical knowledge, and poor
medical facilities.
Access
Report Details @ https://www.marketresearchfuture.com/reports/head-and-neck-cancer-market-5798
Segmentation
The
global head and neck cancer market is segmented on the basis of type of head
and neck cancer, diagnosis, treatment type, and end-user.
On the
basis of type of head and neck cancer, the market is classified as laryngeal
cancer, pharyngeal cancer, salivary gland cancer, lip and oral cavity cancer,
nasopharyngeal cancer, and others.
On the
basis of diagnosis, the market is classified as bioscopy screening tests, blood
tests, dental diagnosis, imaging, and endoscopy. The bioscopy screening tests
are further classified as incisional biopsy, fine needle aspiration biopsy, and
HPV testing. The blood tests are further classified as total cell count tests,
liver function tests, and EBV antibody measurement. The dental diagnosis is
further classified as fluorescence visualization, toluidine blue dye-based
method, acetic acid rinse method, and brush biopsy. The imaging is further classified
as PET/CT, MRI, X-ray, and Barium Swallow test. The endoscopy is further
classified as pharyngoscopy, laryngoscopy, and others.
On the
basis of treatment type, the market is classified as chemotherapy, surgery,
radiation therapy, targeted therapy, and others. The radiation therapy is
further classified as external beam radiation and internal radiation therapy.
On the
basis of the end-user, the market is classified as hospitals, specialty
clinics, and ambulatory surgical centers.
Key
Players
Some of
the key players in the global head and neck cancer market are AB Science SA,
AbbVie Inc., Acceleron Pharma, Inc., AdDent Inc., ASAHI Roentgen, Astellas
Pharma Inc., AstraZeneca Plc., Bayer AG, Boston Biomedical, Inc., Bristol-Myers
Squibb Company, Carestream, Fujifilm Holdings, GE Healthcare, Identafi,
Koninklijke Philips N.V., NeuSoft, Shimadzu Corporation, Siemens Healthcare,
Varian Medical Systems, Xoran, and others.
TABLE OF CONTENT:
Chapter 1. Report
Prologue
Chapter 2. Market Introduction
Chapter 3.
Research Methodology
Chapter 4. Market
Dynamics
Chapter 5. Market
Factor Analysis
Chapter 6. Head
and Neck Cancers Market, By Type
Chapter 7. Head
and Neck Cancers Market, By Diagnosis
Chapter 8. Head
and Neck Cancers Market, By Treatment
Chapter 9. Head
and Neck Cancers Market, By End-User
Chapter 10. Head
and Neck Cancers Market, By Region
Chapter 11.
Company Landscape
Chapter 12 Company
Profiles
Chapter 13 MRFR
Conclusion
Chapter 14
Appendix
No comments:
Post a Comment